Global HER2 Targeted Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 08 Sep 2021

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The HER2 Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global HER2 Targeted Therapy size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global HER2 Targeted Therapy market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
HER2 Targeted Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Monotherapy
    Combination Therapy
    Others

Market segment by Application, can be divided into
    Breast Cancer
    Stomach Cancer
    Head and Neck Cancer
    Lung Cancer
    Ovarian Cancer
    Others

Market segment by players, this report covers
    GlaxoSmithKline
    Bayer
    Abbott
    AbbVie
    Pfizer
    Sanofi
    Agilent
    Glenmark Pharmaceuticals
    Merck
    Roche
    Novartis
    Astra Zeneca
    Daiichi Sankyo

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe HER2 Targeted Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of HER2 Targeted Therapy, with revenue, gross margin and global market share of HER2 Targeted Therapy from 2019 to 2021.
Chapter 3, the HER2 Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and HER2 Targeted Therapy market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe HER2 Targeted Therapy research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of HER2 Targeted Therapy
    1.2 Classification of HER2 Targeted Therapy by Type
        1.2.1 Overview: Global HER2 Targeted Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global HER2 Targeted Therapy Revenue Market Share by Type in 2020
        1.2.3 Monotherapy
        1.2.4 Combination Therapy
        1.2.5 Others
    1.3 Global HER2 Targeted Therapy Market by Application
        1.3.1 Overview: Global HER2 Targeted Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Breast Cancer
        1.3.3 Stomach Cancer
        1.3.4 Head and Neck Cancer
        1.3.5 Lung Cancer
        1.3.6 Ovarian Cancer
        1.3.7 Others
    1.4 Global HER2 Targeted Therapy Market Size & Forecast
    1.5 Global HER2 Targeted Therapy Market Size and Forecast by Region
        1.5.1 Global HER2 Targeted Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global HER2 Targeted Therapy Market Size by Region, (2016-2021)
        1.5.3 North America HER2 Targeted Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe HER2 Targeted Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific HER2 Targeted Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America HER2 Targeted Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa HER2 Targeted Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 HER2 Targeted Therapy Market Drivers
        1.6.2 HER2 Targeted Therapy Market Restraints
        1.6.3 HER2 Targeted Therapy Trends Analysis

2 Company Profiles
    2.1 GlaxoSmithKline
        2.1.1 GlaxoSmithKline Details
        2.1.2 GlaxoSmithKline Major Business
        2.1.3 GlaxoSmithKline HER2 Targeted Therapy Product and Solutions
        2.1.4 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 GlaxoSmithKline Recent Developments and Future Plans
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer HER2 Targeted Therapy Product and Solutions
        2.2.4 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Bayer Recent Developments and Future Plans
    2.3 Abbott
        2.3.1 Abbott Details
        2.3.2 Abbott Major Business
        2.3.3 Abbott HER2 Targeted Therapy Product and Solutions
        2.3.4 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Abbott Recent Developments and Future Plans
    2.4 AbbVie
        2.4.1 AbbVie Details
        2.4.2 AbbVie Major Business
        2.4.3 AbbVie HER2 Targeted Therapy Product and Solutions
        2.4.4 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 AbbVie Recent Developments and Future Plans
    2.5 Pfizer
        2.5.1 Pfizer Details
        2.5.2 Pfizer Major Business
        2.5.3 Pfizer HER2 Targeted Therapy Product and Solutions
        2.5.4 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Pfizer Recent Developments and Future Plans
    2.6 Sanofi
        2.6.1 Sanofi Details
        2.6.2 Sanofi Major Business
        2.6.3 Sanofi HER2 Targeted Therapy Product and Solutions
        2.6.4 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Sanofi Recent Developments and Future Plans
    2.7 Agilent
        2.7.1 Agilent Details
        2.7.2 Agilent Major Business
        2.7.3 Agilent HER2 Targeted Therapy Product and Solutions
        2.7.4 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Agilent Recent Developments and Future Plans
    2.8 Glenmark Pharmaceuticals
        2.8.1 Glenmark Pharmaceuticals Details
        2.8.2 Glenmark Pharmaceuticals Major Business
        2.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Product and Solutions
        2.8.4 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Glenmark Pharmaceuticals Recent Developments and Future Plans
    2.9 Merck
        2.9.1 Merck Details
        2.9.2 Merck Major Business
        2.9.3 Merck HER2 Targeted Therapy Product and Solutions
        2.9.4 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Merck Recent Developments and Future Plans
    2.10 Roche
        2.10.1 Roche Details
        2.10.2 Roche Major Business
        2.10.3 Roche HER2 Targeted Therapy Product and Solutions
        2.10.4 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Roche Recent Developments and Future Plans
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis HER2 Targeted Therapy Product and Solutions
        2.11.4 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Novartis Recent Developments and Future Plans
    2.12 Astra Zeneca
        2.12.1 Astra Zeneca Details
        2.12.2 Astra Zeneca Major Business
        2.12.3 Astra Zeneca HER2 Targeted Therapy Product and Solutions
        2.12.4 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Astra Zeneca Recent Developments and Future Plans
    2.13 Daiichi Sankyo
        2.13.1 Daiichi Sankyo Details
        2.13.2 Daiichi Sankyo Major Business
        2.13.3 Daiichi Sankyo HER2 Targeted Therapy Product and Solutions
        2.13.4 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Daiichi Sankyo Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global HER2 Targeted Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 HER2 Targeted Therapy Players Market Share
        3.2.2 Top 10 HER2 Targeted Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 HER2 Targeted Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global HER2 Targeted Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global HER2 Targeted Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global HER2 Targeted Therapy Revenue Market Share by Application (2016-2021)
    5.2 HER2 Targeted Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America HER2 Targeted Therapy Revenue by Type (2016-2026)
    6.2 North America HER2 Targeted Therapy Revenue by Application (2016-2026)
    6.3 North America HER2 Targeted Therapy Market Size by Country
        6.3.1 North America HER2 Targeted Therapy Revenue by Country (2016-2026)
        6.3.2 United States HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico HER2 Targeted Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe HER2 Targeted Therapy Revenue by Type (2016-2026)
    7.2 Europe HER2 Targeted Therapy Revenue by Application (2016-2026)
    7.3 Europe HER2 Targeted Therapy Market Size by Country
        7.3.1 Europe HER2 Targeted Therapy Revenue by Country (2016-2026)
        7.3.2 Germany HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        7.3.3 France HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy HER2 Targeted Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific HER2 Targeted Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific HER2 Targeted Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific HER2 Targeted Therapy Market Size by Region
        8.3.1 Asia-Pacific HER2 Targeted Therapy Revenue by Region (2016-2026)
        8.3.2 China HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        8.3.5 India HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia HER2 Targeted Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America HER2 Targeted Therapy Revenue by Type (2016-2026)
    9.2 South America HER2 Targeted Therapy Revenue by Application (2016-2026)
    9.3 South America HER2 Targeted Therapy Market Size by Country
        9.3.1 South America HER2 Targeted Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina HER2 Targeted Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa HER2 Targeted Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa HER2 Targeted Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa HER2 Targeted Therapy Market Size by Country
        10.3.1 Middle East & Africa HER2 Targeted Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia HER2 Targeted Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE HER2 Targeted Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global HER2 Targeted Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global HER2 Targeted Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market HER2 Targeted Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global HER2 Targeted Therapy Revenue (USD Million) by Region (2016-2021)
    Table 5. Global HER2 Targeted Therapy Revenue Market Share by Region (2021-2026)
    Table 6. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
    Table 7. GlaxoSmithKline Major Business
    Table 8. GlaxoSmithKline HER2 Targeted Therapy Product and Solutions
    Table 9. GlaxoSmithKline HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Bayer Corporate Information, Head Office, and Major Competitors
    Table 11. Bayer Major Business
    Table 12. Bayer HER2 Targeted Therapy Product and Solutions
    Table 13. Bayer HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Abbott Corporate Information, Head Office, and Major Competitors
    Table 15. Abbott Major Business
    Table 16. Abbott HER2 Targeted Therapy Product and Solutions
    Table 17. Abbott HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. AbbVie Corporate Information, Head Office, and Major Competitors
    Table 19. AbbVie Major Business
    Table 20. AbbVie HER2 Targeted Therapy Product and Solutions
    Table 21. AbbVie HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 23. Pfizer Major Business
    Table 24. Pfizer HER2 Targeted Therapy Product and Solutions
    Table 25. Pfizer HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Sanofi Corporate Information, Head Office, and Major Competitors
    Table 27. Sanofi Major Business
    Table 28. Sanofi HER2 Targeted Therapy Product and Solutions
    Table 29. Sanofi HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Agilent Corporate Information, Head Office, and Major Competitors
    Table 31. Agilent Major Business
    Table 32. Agilent HER2 Targeted Therapy Product and Solutions
    Table 33. Agilent HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Glenmark Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 35. Glenmark Pharmaceuticals Major Business
    Table 36. Glenmark Pharmaceuticals HER2 Targeted Therapy Product and Solutions
    Table 37. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Merck Corporate Information, Head Office, and Major Competitors
    Table 39. Merck Major Business
    Table 40. Merck HER2 Targeted Therapy Product and Solutions
    Table 41. Merck HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Roche Corporate Information, Head Office, and Major Competitors
    Table 43. Roche Major Business
    Table 44. Roche HER2 Targeted Therapy Product and Solutions
    Table 45. Roche HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. Novartis Corporate Information, Head Office, and Major Competitors
    Table 47. Novartis Major Business
    Table 48. Novartis HER2 Targeted Therapy Product and Solutions
    Table 49. Novartis HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Astra Zeneca Corporate Information, Head Office, and Major Competitors
    Table 51. Astra Zeneca Major Business
    Table 52. Astra Zeneca HER2 Targeted Therapy Product and Solutions
    Table 53. Astra Zeneca HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
    Table 55. Daiichi Sankyo Major Business
    Table 56. Daiichi Sankyo HER2 Targeted Therapy Product and Solutions
    Table 57. Daiichi Sankyo HER2 Targeted Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Global HER2 Targeted Therapy Revenue (USD Million) by Players (2019-2021)
    Table 59. Global HER2 Targeted Therapy Revenue Share by Players (2019-2021)
    Table 60. Breakdown of HER2 Targeted Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 61. HER2 Targeted Therapy Players Head Office, Products and Services Provided
    Table 62. HER2 Targeted Therapy Mergers & Acquisitions in the Past Five Years
    Table 63. HER2 Targeted Therapy New Entrants and Expansion Plans
    Table 64. Global HER2 Targeted Therapy Revenue (USD Million) by Type (2016-2021)
    Table 65. Global HER2 Targeted Therapy Revenue Share by Type (2016-2021)
    Table 66. Global HER2 Targeted Therapy Revenue Forecast by Type (2021-2026)
    Table 67. Global HER2 Targeted Therapy Revenue by Application (2016-2021)
    Table 68. Global HER2 Targeted Therapy Revenue Forecast by Application (2021-2026)
    Table 69. North America HER2 Targeted Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 70. North America HER2 Targeted Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 71. North America HER2 Targeted Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 72. North America HER2 Targeted Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 73. North America HER2 Targeted Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 74. North America HER2 Targeted Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 75. Europe HER2 Targeted Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 76. Europe HER2 Targeted Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 77. Europe HER2 Targeted Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 78. Europe HER2 Targeted Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 79. Europe HER2 Targeted Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 80. Europe HER2 Targeted Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 81. Asia-Pacific HER2 Targeted Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 82. Asia-Pacific HER2 Targeted Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 83. Asia-Pacific HER2 Targeted Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 84. Asia-Pacific HER2 Targeted Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 85. Asia-Pacific HER2 Targeted Therapy Revenue by Region (2016-2021) & (USD Million)
    Table 86. Asia-Pacific HER2 Targeted Therapy Revenue by Region (2021-2026) & (USD Million)
    Table 87. South America HER2 Targeted Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 88. South America HER2 Targeted Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 89. South America HER2 Targeted Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 90. South America HER2 Targeted Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 91. South America HER2 Targeted Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 92. South America HER2 Targeted Therapy Revenue by Country (2021-2026) & (USD Million)
    Table 93. Middle East & Africa HER2 Targeted Therapy Revenue by Type (2016-2021) & (USD Million)
    Table 94. Middle East & Africa HER2 Targeted Therapy Revenue by Type (2021-2026) & (USD Million)
    Table 95. Middle East & Africa HER2 Targeted Therapy Revenue by Application (2016-2021) & (USD Million)
    Table 96. Middle East & Africa HER2 Targeted Therapy Revenue by Application (2021-2026) & (USD Million)
    Table 97. Middle East & Africa HER2 Targeted Therapy Revenue by Country (2016-2021) & (USD Million)
    Table 98. Middle East & Africa HER2 Targeted Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. HER2 Targeted Therapy Picture
    Figure 2. Global HER2 Targeted Therapy Revenue Market Share by Type in 2020
    Figure 3. Monotherapy
    Figure 4. Combination Therapy
    Figure 5. Others
    Figure 6. HER2 Targeted Therapy Revenue Market Share by Application in 2020
    Figure 7. Breast Cancer Picture
    Figure 8. Stomach Cancer Picture
    Figure 9. Head and Neck Cancer Picture
    Figure 10. Lung Cancer Picture
    Figure 11. Ovarian Cancer Picture
    Figure 12. Others Picture
    Figure 13. Global HER2 Targeted Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 14. Global HER2 Targeted Therapy Revenue and Forecast (2016-2026) & (USD Million)
    Figure 15. Global HER2 Targeted Therapy Revenue Market Share by Region (2016-2026)
    Figure 16. Global HER2 Targeted Therapy Revenue Market Share by Region in 2020
    Figure 17. North America HER2 Targeted Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Europe HER2 Targeted Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Asia-Pacific HER2 Targeted Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. South America HER2 Targeted Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. Middle East and Africa HER2 Targeted Therapy Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. HER2 Targeted Therapy Market Drivers
    Figure 23. HER2 Targeted Therapy Market Restraints
    Figure 24. HER2 Targeted Therapy Market Trends
    Figure 25. GlaxoSmithKline Recent Developments and Future Plans
    Figure 26. Bayer Recent Developments and Future Plans
    Figure 27. Abbott Recent Developments and Future Plans
    Figure 28. AbbVie Recent Developments and Future Plans
    Figure 29. Pfizer Recent Developments and Future Plans
    Figure 30. Sanofi Recent Developments and Future Plans
    Figure 31. Agilent Recent Developments and Future Plans
    Figure 32. Glenmark Pharmaceuticals Recent Developments and Future Plans
    Figure 33. Merck Recent Developments and Future Plans
    Figure 34. Roche Recent Developments and Future Plans
    Figure 35. Novartis Recent Developments and Future Plans
    Figure 36. Astra Zeneca Recent Developments and Future Plans
    Figure 37. Daiichi Sankyo Recent Developments and Future Plans
    Figure 38. Global HER2 Targeted Therapy Revenue Share by Players in 2020
    Figure 39. HER2 Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 40. Global Top 3 Players HER2 Targeted Therapy Revenue Market Share in 2020
    Figure 41. Global Top 10 Players HER2 Targeted Therapy Revenue Market Share in 2020
    Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 43. Global HER2 Targeted Therapy Revenue Share by Type in 2020
    Figure 44. Global HER2 Targeted Therapy Market Share Forecast by Type (2021-2026)
    Figure 45. Global HER2 Targeted Therapy Revenue Share by Application in 2020
    Figure 46. Global HER2 Targeted Therapy Market Share Forecast by Application (2021-2026)
    Figure 47. North America HER2 Targeted Therapy Sales Market Share by Type (2016-2026)
    Figure 48. North America HER2 Targeted Therapy Sales Market Share by Application (2016-2026)
    Figure 49. North America HER2 Targeted Therapy Revenue Market Share by Country (2016-2026)
    Figure 50. United States HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Canada HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Mexico HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Europe HER2 Targeted Therapy Sales Market Share by Type (2016-2026)
    Figure 54. Europe HER2 Targeted Therapy Sales Market Share by Application (2016-2026)
    Figure 55. Europe HER2 Targeted Therapy Revenue Market Share by Country (2016-2026)
    Figure 56. Germany HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. France HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. United Kingdom HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Russia HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Italy HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Asia-Pacific HER2 Targeted Therapy Sales Market Share by Type (2016-2026)
    Figure 62. Asia-Pacific HER2 Targeted Therapy Sales Market Share by Application (2016-2026)
    Figure 63. Asia-Pacific HER2 Targeted Therapy Revenue Market Share by Region (2016-2026)
    Figure 64. China HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Japan HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. South Korea HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. India HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Southeast Asia HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. Australia HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. South America HER2 Targeted Therapy Sales Market Share by Type (2016-2026)
    Figure 71. South America HER2 Targeted Therapy Sales Market Share by Application (2016-2026)
    Figure 72. South America HER2 Targeted Therapy Revenue Market Share by Country (2016-2026)
    Figure 73. Brazil HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Argentina HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 75. Middle East and Africa HER2 Targeted Therapy Sales Market Share by Type (2016-2026)
    Figure 76. Middle East and Africa HER2 Targeted Therapy Sales Market Share by Application (2016-2026)
    Figure 77. Middle East and Africa HER2 Targeted Therapy Revenue Market Share by Country (2016-2026)
    Figure 78. Turkey HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Saudi Arabia HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. UAE HER2 Targeted Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 81. Methodology
    Figure 82. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Agilent
Glenmark Pharmaceuticals
Merck
Roche
Novartis
Astra Zeneca
Daiichi Sankyo

Related Reports

Global HER2 Targeted Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global HER2 Targeted Therapy Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Medical Care

The HER2 Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global HER2 Targeted Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global HER2 Targeted Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 30 Aug 2023

date Medical Care

According to our (Global Info Research) latest study, the global HER2 Targeted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Global HER2 Targeted Therapy Supply, Demand and Key Producers, 2023-2029

Global HER2 Targeted Therapy Supply, Demand and Key Producers, 2023-2029

date 30 Aug 2023

date Medical Care

The global HER2 Targeted Therapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global HER2 Targeted Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global HER2 Targeted Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global HER2 Targeted Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global HER2 Targeted Therapy Supply, Demand and Key Producers, 2024-2030

Global HER2 Targeted Therapy Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Medical Care

The global HER2 Targeted Therapy market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

her2 targeted therapy

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>